< previous page | page_323 | next page >
Page 323
| spreading and manifesting in another location. I feel that enough data for creating a specific natural protocol can be provided by clinical information, primary tumor characteristics, and the patient herself. |
| Breast-Conserving Surgery |
| The use of lumpectomy for breast cancer increased from 16 percent in 1983 to 37 percent in 1991, while use of modified radical mastectomy declined from 75 percent to 58 percent in the same period. Lumpectomy was used more frequently for early-stage breast cancer than for later stages of the disease. By 1991, more than 50 percent of in situ cases and slightly fewer than 50 percent of Stage I cases were treated with lumpectomy. 47 |
| Reasons not to use breast-conserving surgery include: |
| Large tumor size |
| Multifocal breast carcinoma |
| Lobula carcinoma |
| Tumor necrosis |
| High S-phase (stage during which DNA is synthesized) |
| Low estrogen-receptor content |
| Vessel invasion and lymph node metastases |
| Certain mammographic patterns |
| Premenopausal |
| Overexpression of the mutant p53 protein and/or erbB-2 |
| Overexpression of glutathione S-transferase 48 |
| Low levels of alpha-linolenic acid (ALA) and high levels of prostaglandin E2.49 |
| My View |
| I believe that surgery can actually enhance the growth of systemic cancer because the removal of a tumor creates a tremendous amount of damage to healthy tissue and causes significant inflammation. Inflammation and the breakdown of tissue create an environment of very high free-radical activity in which cells are actively dividing in order to replace damaged cells, thus making |
< previous page | page_323 | next page >

If you like this book, buy it!